{"id":"https://openalex.org/W2013671556","doi":"https://doi.org/10.1089/jop.2007.0012","title":"Short-Term Results of Intravitreal Bevacizumab for Macular Edema with Retinal Vein Obstruction and Diabetic Macular Edema","display_name":"Short-Term Results of Intravitreal Bevacizumab for Macular Edema with Retinal Vein Obstruction and Diabetic Macular Edema","publication_year":2007,"publication_date":"2007-08-01","ids":{"openalex":"https://openalex.org/W2013671556","doi":"https://doi.org/10.1089/jop.2007.0012","mag":"2013671556","pmid":"https://pubmed.ncbi.nlm.nih.gov/17803438"},"language":"en","primary_location":{"id":"doi:10.1089/jop.2007.0012","doi":"https://doi.org/10.1089/jop.2007.0012","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2007.0012","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://ir.ymlib.yonsei.ac.kr/handle/22282913/96500","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024115656","display_name":"Suk Ho Byeon","orcid":"https://orcid.org/0000-0001-8101-0830","observed_orcids":["https://orcid.org/0000-0001-8101-0830","https://orcid.org/0000-0003-0913-8623"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Suk H. Byeon","raw_affiliation_strings":["Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103440744","display_name":"Young A Kwon","orcid":"https://orcid.org/0009-0009-2213-2227","observed_orcids":["https://orcid.org/0009-0009-2213-2227"]},"institutions":[{"id":"https://openalex.org/I165028127","display_name":"Konyang University","ror":"https://ror.org/02v8yp068","country_code":"KR","type":"education","lineage":["https://openalex.org/I165028127"]},{"id":"https://openalex.org/I4210117632","display_name":"Kim's Eye Hospital","ror":"https://ror.org/02nh1np55","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210117632"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Young A. Kwon","raw_affiliation_strings":["Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Seoul, Korea","institution_ids":["https://openalex.org/I165028127","https://openalex.org/I4210117632"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109420648","display_name":"Hyun Sub Oh","orcid":"https://orcid.org/0000-0001-9868-1438","observed_orcids":["https://orcid.org/0000-0001-9868-1438"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Hyun-Sub Oh","raw_affiliation_strings":["Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100383170","display_name":"Min Kim","orcid":"https://orcid.org/0000-0003-1873-6959","observed_orcids":["https://orcid.org/0000-0003-1873-6959"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Min Kim","raw_affiliation_strings":["Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087042980","display_name":"Oh Woong Kwon","orcid":"https://orcid.org/0000-0001-9786-6756","observed_orcids":["https://orcid.org/0000-0001-9786-6756"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Oh W. Kwon","raw_affiliation_strings":["Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4811,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":{"value":0.91111482,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"23","issue":"4","first_page":"387","last_page":"394"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9070000052452087},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9900000095367432},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.9620000123977661},{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":0.9990000128746033},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/visual-acuity","display_name":"visual acuity","score":0.8450000286102295},{"id":"https://openalex.org/keywords/central-retinal-thickness","display_name":"central retinal thickness","score":0.9890000224113464},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.8209999799728394},{"id":"https://openalex.org/keywords/repeated-injections","display_name":"multiple injection","score":0.7789999842643738},{"id":"https://openalex.org/keywords/short-term-outcomes","display_name":"short-term outcomes","score":0.6840000152587891},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.4970000088214874},{"id":"https://openalex.org/keywords/retinal-neovascularization","display_name":"retinal neovascularization","score":0.5370000004768372},{"id":"https://openalex.org/keywords/retinal-ischemia","display_name":"retinal ischemia","score":0.4399999976158142},{"id":"https://openalex.org/keywords/retinal-edema","display_name":"retinal edema","score":0.4399999976158142}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9258252382278442},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.7602828741073608},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7288466691970825},{"id":"https://openalex.org/C2780347916","wikidata":"https://www.wikidata.org/wiki/Q1813737","display_name":"Macular edema","level":3,"score":0.6863685846328735},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.616736114025116},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.5317099690437317},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.49737122654914856},{"id":"https://openalex.org/C2908732032","wikidata":"https://www.wikidata.org/wiki/Q5062148","display_name":"Retinal Vein","level":3,"score":0.4941740334033966},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.4602137804031372},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4038572907447815},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.3802064061164856},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2898053228855133},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07887205481529236},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007267","descriptor_name":"Injections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008269","descriptor_name":"Macular Edema","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D012170","descriptor_name":"Retinal Vein Occlusion","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014787","descriptor_name":"Vision Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014792","descriptor_name":"Visual Acuity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D041623","descriptor_name":"Tomography, Optical Coherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1089/jop.2007.0012","doi":"https://doi.org/10.1089/jop.2007.0012","is_oa":false,"landing_page_url":"https://doi.org/10.1089/jop.2007.0012","pdf_url":null,"source":{"id":"https://openalex.org/S192126995","display_name":"Journal of Ocular Pharmacology and Therapeutics","issn_l":"1080-7683","issn":["1080-7683","1557-7732","8756-3320"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Ocular Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:17803438","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17803438","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:ir.ymlib.yonsei.ac.kr:22282913/96500","doi":null,"is_oa":true,"landing_page_url":"https://ir.ymlib.yonsei.ac.kr/handle/22282913/96500","pdf_url":null,"source":{"id":"https://openalex.org/S4306400691","display_name":"YUHSpace (Yonsei University Medical Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193775966","host_organization_name":"Yonsei University","host_organization_lineage":["https://openalex.org/I193775966"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:ir.ymlib.yonsei.ac.kr:22282913/96500","doi":null,"is_oa":true,"landing_page_url":"https://ir.ymlib.yonsei.ac.kr/handle/22282913/96500","pdf_url":null,"source":{"id":"https://openalex.org/S4306400691","display_name":"YUHSpace (Yonsei University Medical Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193775966","host_organization_name":"Yonsei University","host_organization_lineage":["https://openalex.org/I193775966"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W1496977463","https://openalex.org/W1522623672","https://openalex.org/W1579034041","https://openalex.org/W1971349804","https://openalex.org/W1976903522","https://openalex.org/W1976993504","https://openalex.org/W1982265214","https://openalex.org/W1989729487","https://openalex.org/W1997096485","https://openalex.org/W2003640321","https://openalex.org/W2008152614","https://openalex.org/W2023523208","https://openalex.org/W2024840874","https://openalex.org/W2029126623","https://openalex.org/W2033245558","https://openalex.org/W2033549802","https://openalex.org/W2042261909","https://openalex.org/W2051479732","https://openalex.org/W2052887664","https://openalex.org/W2085366579","https://openalex.org/W2092227694","https://openalex.org/W2106794880","https://openalex.org/W2119074953","https://openalex.org/W2119981835","https://openalex.org/W2128535483","https://openalex.org/W2130642901","https://openalex.org/W4229761845","https://openalex.org/W4235001346","https://openalex.org/W4240304626","https://openalex.org/W4254778823","https://openalex.org/W4256306353"],"related_works":["https://openalex.org/W2016533065","https://openalex.org/W2030362969","https://openalex.org/W4412670910","https://openalex.org/W1973438932","https://openalex.org/W3030873261","https://openalex.org/W1973556906","https://openalex.org/W2150171454","https://openalex.org/W2093446675","https://openalex.org/W2129793174","https://openalex.org/W2061036262"],"abstract_inverted_index":{"OBJECTIVE:":[0],"The":[1,101,124],"aim":[2],"of":[3,15,42,118,204,212],"this":[4],"study":[5],"was":[6,104,120,128,136,150,178,286],"to":[7,249],"identify":[8],"the":[9,115,133,147,175,226],"short-term":[10],"effect,":[11],"safety,":[12,73],"and":[13,31,51,61,83,132,144,166,174,193,234,242,268,284,288,294],"durability":[14],"intravitreally":[16],"injected":[17],"bevacizumab":[18,58,238,277],"in":[19,255],"patients":[20],"with":[21,46,53,78,207],"macular":[22,33],"edema":[23,34],"(ME)":[24],"caused":[25,48,232,281],"by":[26,49,282],"retinal":[27,85],"vein":[28],"obstruction":[29],"(RVO)":[30],"diabetic":[32],"(DME).":[35],"METHODS:":[36],"We":[37],"retrospectively":[38],"evaluated":[39],"39":[40],"eyes":[41,206],"36":[43],"patients,":[44,236],"14":[45],"ME":[47,231,280],"RVO":[50,233,283],"25":[52],"DME,":[54],"who":[55],"received":[56],"intravitreal":[57,276],"(1.25":[59],"mg)":[60],"were":[62,99],"followed":[63],"up":[64],"for":[65,253,279,290],"at":[66,218,244,257],"least":[67],"3":[68,145,210],"months.":[69],"Monthly":[70],"assessments":[71],"examined":[72],"best":[74],"corrected":[75],"visual":[76,292],"acuity":[77,293],"an":[79],"ETDRS":[80],"chart":[81],"(logMAR),":[82],"central":[84],"thickness":[86],"(CRT)":[87],"using":[88],"optical":[89],"coherence":[90],"tomography.":[91],"RESULTS:":[92],"No":[93],"significant":[94],"ocular":[95],"or":[96],"systemic":[97],"side-effects":[98],"observed.":[100],"follow-up":[102,213],"period":[103],"5.4":[105],"+/-":[106,110,122,130,138,152,161,168,180,187,195,222],"1.1":[107],"months":[108,211,224,264,270],"(mean":[109],"standard":[111],"deviation).":[112],"During":[113],"follow-up,":[114],"mean":[116,126,134,148,176,220],"number":[117],"injections":[119],"1.4":[121],"0.5.":[123],"baseline":[125],"logMAR":[127,149,241,254],"0.91":[129],"0.51,":[131],"CRT":[135,177,243],"552.6":[137],"186.7":[139],"microm.":[140],"At":[141],"1,":[142],"2,":[143],"months,":[146,251],"0.67":[151],"0.46":[153,162],"(paired":[154],"t":[155],"test,":[156],"P":[157],"<":[158,164,171,184,191,199],"0.001),":[159,165,172,185,192,200],"0.66":[160],"(P":[163,170,183,190,198,260,265,271],"0.69":[167],"0.45":[169],"respectively,":[173],"323.1":[179],"151.9":[181],"mum":[182,189],"324.6":[186],"136.9":[188],"382.5":[194],"130.4":[196],"microm":[197],"respectively.":[201],"Fourteen":[202],"(14)":[203],"34":[205],"more":[208],"than":[209],"required":[214],"a":[215,219,237],"second":[216],"injection":[217,278],"3.4":[221],"1.0":[223],"after":[225],"initial":[227],"injection.":[228],"For":[229],"both":[230],"DME":[235,256,285],"administration":[239],"improved":[240],"each":[245],"time":[246],"point":[247],"through":[248],"6":[250,269],"except":[252],"1":[258],"week":[259],"=":[261,266,272],"0.081),":[262],"5":[263],"0.130)":[267],"0.759).":[273],"CONCLUSIONS:":[274],"An":[275],"safe":[287],"effective":[289],"improving":[291],"reducing":[295],"CRT.":[296]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}